Form 4: Nevro Corp Director Michael DeMane Reports Stock Transactions

Director Michael F. DeMane reports acquisition of 3,117 shares of Nevro Corp common stock and disposal of an unspecified amount on June 30, 2024.

Summary

• Michael F. DeMane, a director of Nevro Corp, filed a Form 4 detailing changes in beneficial ownership.
• On June 30, 2024, DeMane acquired 3,117 shares of common stock.
• These shares were received as fully vested restricted stock in lieu of cash retainer fees.
• DeMane also disposed of an unspecified amount of common stock on the same date.
• Following the reported transactions, DeMane directly owns 50,112 shares, including 19,169 restricted stock units.
• Additionally, DeMane indirectly owns 164,344 shares through the Michael F. DeMane 2012 Irrevocable Trust, 219,145 shares through the Michael F. DeMane 2017 Family SLAT Trust, and 58,266 shares through the Michael F. DeMane Revocable Trust.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of stock transactions. The acquisition is slightly positive, but the disposal offsets it.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future.

Negatives

• The disposal of an unspecified amount of shares by a director could be interpreted negatively, although the reason for disposal is not provided.

Risks

• The Form 4 filing itself doesn't inherently indicate risks, but monitoring insider transactions is crucial for assessing potential risks related to management's perspective on the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Monitoring these transactions can provide insights into management's sentiment and potential future performance.

Stakeholder Impact

• The stock transactions may have a minor impact on shareholders' perception of the company.

Key Dates